the long lodge, 265-269 kingston road, london, SW19 3NW
Website
-
dr kunde limitedEstimated Valuation
£34k
Pomanda estimates the enterprise value of DR KUNDE LIMITED at £34k based on a Turnover of £85.3k and 0.4x industry multiple (adjusted for size and gross margin).
dr kunde limitedEstimated Valuation
£117.7k
Pomanda estimates the enterprise value of DR KUNDE LIMITED at £117.7k based on an EBITDA of £43.2k and a 2.73x industry multiple (adjusted for size and gross margin).
dr kunde limitedEstimated Valuation
£7.9m
Pomanda estimates the enterprise value of DR KUNDE LIMITED at £7.9m based on Net Assets of £3.5m and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dr Kunde LimitedOverview
Dr Kunde Limited is a live company located in london, SW19 3NW with a Companies House number of 08026019. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in April 2012, it's largest shareholder is
amisha kunde
with a 23.1% stake. Dr Kunde Limited is a established,
micro sized company, Pomanda has estimated its turnover at
£85.3k with
healthy
growth in recent years.
Pomanda's financial health check has awarded Dr Kunde Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
5 Strong
2 Regular
4 Weak
Size
annual sales of £85.3k, make it smaller than the average company (£393.7k)
£85.3k - Dr Kunde Limited
£393.7k - Industry AVG
Growth
3 year (CAGR) sales growth of 11%, show it is growing at a faster rate (8.2%)
11% - Dr Kunde Limited
8.2% - Industry AVG
Production
with a gross margin of 30.2%, this company has a higher cost of product (54%)
30.2% - Dr Kunde Limited
54% - Industry AVG
Profitability
an operating margin of 50.6% make it more profitable than the average company (14%)
50.6% - Dr Kunde Limited
14% - Industry AVG
Employees
with 1 employees, this is below the industry average (7)
1 - Dr Kunde Limited
7 - Industry AVG
Pay Structure
on an average salary of £30.9k, the company has an equivalent pay structure (£30.9k)
£30.9k - Dr Kunde Limited
£30.9k - Industry AVG
Efficiency
resulting in sales per employee of £85.3k, this is equally as efficient (£76.6k)
£85.3k - Dr Kunde Limited
£76.6k - Industry AVG
Debtor Days
it gets paid by customers after 57 days, this is later than average (36 days)
57 days - Dr Kunde Limited
36 days - Industry AVG
Creditor Days
its suppliers are paid after 611 days, this is slower than average (37 days)
611 days - Dr Kunde Limited
37 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Dr Kunde Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 1397 weeks, this is more cash available to meet short term requirements (74 weeks)
1397 weeks - Dr Kunde Limited
74 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2.7%, this is a lower level of debt than the average (33.6%)
2.7% - Dr Kunde Limited
33.6% - Industry AVG
DR KUNDE LIMITED financials
EXPORT
Dr Kunde Limited's latest turnover from January 2024 is estimated at £85.3 thousand and the company has net assets of £3.5 million. According to their latest financial statements, Dr Kunde Limited has 1 employee and maintains cash reserves of £2.7 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jan 2024
Jan 2023
Jan 2022
Jan 2021
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Jan 2016
Jan 2015
Jan 2014
Jan 2013
Turnover
85,325
75,844
65,354
62,260
107,799
38,190
224,658
241,558
345,888
357,284
437,968
528,519
Other Income Or Grants
Cost Of Sales
59,597
51,297
41,202
41,702
66,388
21,807
124,122
124,155
183,588
178,367
233,504
242,770
Gross Profit
25,727
24,547
24,152
20,558
41,411
16,383
100,536
117,403
162,300
178,917
204,465
285,749
Admin Expenses
-17,447
-307,506
-357,719
-312,797
-419,606
-293,870
-260,625
-305,377
-170,225
-155,549
-296,971
-84,484
Operating Profit
43,174
332,053
381,871
333,355
461,017
310,253
361,161
422,780
332,525
334,466
501,436
370,233
Interest Payable
Interest Receivable
137,934
80,062
4,594
1,560
10,233
8,364
6,157
3,310
4,813
3,651
2,565
888
Pre-Tax Profit
181,108
412,115
386,465
334,915
471,251
318,617
367,319
426,090
337,338
338,118
504,001
371,121
Tax
-45,277
-78,302
-73,428
-63,634
-89,538
-60,537
-69,791
-85,218
-67,467
-71,005
-115,920
-89,069
Profit After Tax
135,831
333,813
313,037
271,281
381,713
258,080
297,528
340,872
269,870
267,113
388,081
282,052
Dividends Paid
Retained Profit
135,831
333,813
313,037
271,281
381,713
258,080
297,528
340,872
269,870
267,113
388,081
282,052
Employee Costs
30,886
29,020
26,973
26,064
25,083
27,043
48,550
56,144
84,134
88,141
90,316
137,468
Number Of Employees
1
1
1
1
1
1
2
2
3
3
3
5
EBITDA*
43,174
332,053
381,871
333,355
461,017
310,253
361,161
429,960
342,100
335,288
501,747
370,233
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jan 2024
Jan 2023
Jan 2022
Jan 2021
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Jan 2016
Jan 2015
Jan 2014
Jan 2013
Tangible Assets
142,873
157,497
6,742
7,790
10,387
13,848
16,882
21,541
28,721
2,468
932
Intangible Assets
Investments & Other
800,000
800,000
1,149,000
1,149,000
1,149,000
899,000
899,000
116,234
105,000
102,600
56,000
Debtors (Due After 1 year)
Total Fixed Assets
942,873
957,497
1,155,742
1,156,790
1,159,387
912,848
915,882
137,775
133,721
105,068
56,932
Stock & work in progress
Trade Debtors
13,496
10,075
12,843
10,403
721
61,855
42,668
67,896
66,339
81,479
92,358
Group Debtors
Misc Debtors
2,481
Cash
2,684,094
2,570,548
2,004,427
1,670,965
1,449,080
1,279,798
950,672
1,512,310
1,135,510
789,509
671,082
355,057
misc current assets
total current assets
2,697,590
2,580,623
2,017,270
1,681,368
1,449,080
1,280,519
1,012,527
1,554,978
1,205,887
855,848
752,561
447,415
total assets
3,640,463
3,538,120
3,173,012
2,838,158
2,608,467
2,193,367
1,928,409
1,692,753
1,339,608
960,916
809,493
447,415
Bank overdraft
Bank loan
Trade Creditors
99,892
133,380
102,085
80,268
121,858
86,887
79,865
295
22,670
138,360
164,363
Group/Directors Accounts
41,574
49,296
other short term finances
hp & lease commitments
other current liabilities
102,191
81,901
total current liabilities
99,892
133,380
102,085
80,268
121,858
86,887
79,865
143,765
131,492
22,670
138,360
164,363
loans
hp & lease commitments
Accruals and Deferred Income
1,584
1,728
other liabilities
provisions
total long term liabilities
1,584
1,728
total liabilities
99,892
133,380
102,085
80,268
121,858
88,471
81,593
143,765
131,492
22,670
138,360
164,363
net assets
3,540,571
3,404,740
3,070,927
2,757,890
2,486,609
2,104,896
1,846,816
1,548,988
1,208,116
938,246
671,133
283,052
total shareholders funds
3,540,571
3,404,740
3,070,927
2,757,890
2,486,609
2,104,896
1,846,816
1,548,988
1,208,116
938,246
671,133
283,052
Jan 2024
Jan 2023
Jan 2022
Jan 2021
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Jan 2016
Jan 2015
Jan 2014
Jan 2013
Operating Activities
Operating Profit
43,174
332,053
381,871
333,355
461,017
310,253
361,161
422,780
332,525
334,466
501,436
370,233
Depreciation
7,180
9,575
822
311
Amortisation
Tax
-45,277
-78,302
-73,428
-63,634
-89,538
-60,537
-69,791
-85,218
-67,467
-71,005
-115,920
-89,069
Stock
Debtors
3,421
-2,768
2,440
10,403
-721
-61,134
19,187
-27,709
4,038
-15,140
-10,879
92,358
Creditors
-33,488
31,295
21,817
-41,590
34,971
7,022
79,865
-295
-22,375
-115,690
-26,003
164,363
Accruals and Deferred Income
-1,584
-144
-100,463
20,290
81,901
Deferred Taxes & Provisions
Cash flow from operations
-39,012
287,814
327,820
217,728
405,587
317,728
251,585
392,446
330,121
163,733
370,703
353,169
Investing Activities
capital expenditure
14,624
-150,755
1,048
2,597
3,461
3,034
4,659
-35,828
-2,358
-1,243
Change in Investments
-349,000
250,000
782,766
11,234
2,400
46,600
56,000
cash flow from investments
14,624
198,245
1,048
2,597
-246,539
3,034
-778,107
-11,234
-38,228
-48,958
-57,243
Financing Activities
Bank loans
Group/Directors Accounts
-41,574
-7,722
49,296
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
300
1,000
interest
137,934
80,062
4,594
1,560
10,233
8,364
6,157
3,310
4,813
3,651
2,565
888
cash flow from financing
137,934
80,062
4,594
1,560
10,233
8,364
-35,117
-4,412
54,109
3,651
2,565
1,888
cash and cash equivalents
cash
113,546
566,121
333,462
221,885
169,282
329,126
-561,638
376,800
346,001
118,427
316,025
355,057
overdraft
change in cash
113,546
566,121
333,462
221,885
169,282
329,126
-561,638
376,800
346,001
118,427
316,025
355,057
dr kunde limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for dr kunde limited. Get real-time insights into dr kunde limited's credit score, group structure and payment trends.
Perform a competitor analysis for dr kunde limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in SW19 area or any other competitors across 12 key performance metrics.
the long lodge, 265-269 kingston road, london, SW19 3NW
Bank
LLOYDS TSB BANK PLC
Legal Advisor
-
dr kunde limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to dr kunde limited.
dr kunde limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DR KUNDE LIMITED. This can take several minutes, an email will notify you when this has completed.
dr kunde limitedCompanies House Filings - See Documents
